Covered recipient · General Payments record
EHAD AFREEN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,387.49
- Reported across 82 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $373.44 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $195.56 | 19 |
| Alexion Pharmaceuticals, Inc. | $75.53 | 4 |
| EMD Serono, Inc. | $49.64 | 3 |
| UCB, Inc. | $34.29 | 2 |
| Teva Pharmaceuticals USA, Inc. | $18.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.29 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178128 | CMS |
| ABBVIE INC. | $8.18 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178130 | CMS |
| ABBVIE INC. | $6.60 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178132 | CMS |
| ABBVIE INC. | $2.55 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178134 | CMS |
| ABBVIE INC. | $7.90 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178136 | CMS |
| ABBVIE INC. | $5.72 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178138 | CMS |
| ABBVIE INC. | $4.92 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178140 | CMS |
| ABBVIE INC. | $13.68 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178142 | CMS |
| ABBVIE INC. | $15.89 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178144 | CMS |
| ABBVIE INC. | $17.29 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178146 | CMS |
| ABBVIE INC. | $16.24 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178148 | CMS |
| ABBVIE INC. | $5.61 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178150 | CMS |
| ABBVIE INC. | $21.91 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178152 | CMS |
| ABBVIE INC. | $27.05 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178154 | CMS |
| ABBVIE INC. | $4.44 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178156 | CMS |
| ABBVIE INC. | $19.15 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178158 | CMS |
| ABBVIE INC. | $4.50 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178160 | CMS |
| ABBVIE INC. | $8.12 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178162 | CMS |
| ABBVIE INC. | $3.52 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103178164 | CMS |
| Alexion Pharmaceuticals, Inc. | $13.30 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093963500 | CMS |
| Alexion Pharmaceuticals, Inc. | $19.13 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094047236 | CMS |
| Alexion Pharmaceuticals, Inc. | $26.40 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093974113 | CMS |
| Alexion Pharmaceuticals, Inc. | $16.70 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093913016 | CMS |
| EMD Serono, Inc. | $13.91 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120247913 | CMS |
| EMD Serono, Inc. | $15.18 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120219817 | CMS |
| EMD Serono, Inc. | $20.55 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120265075 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.42 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151509144 | CMS |
| UCB, Inc. | $13.09 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143144253 | CMS |
| UCB, Inc. | $21.20 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143144257 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.